regulatory
confidence high
sentiment positive
materiality 0.65
Acasti Pharma regains Nasdaq minimum bid price compliance after reverse split
Grace Therapeutics, Inc.
- Received Nasdaq notice on July 24, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Compliance achieved through a 1-for-6 reverse share split effective July 10, 2023.
- Company continues trading on Nasdaq Capital Market under symbol ACST.